×

Healthcare

USD Analytics healthcare data solutions deliver information, analytics, and solutions for the world’s major medical device, pharmaceutical companies, financial markets, and governments. The company leverages its vast databases and industry expertise to present in-depth and up-to-date analyses of healthcare industries. The solution enables users to make efficient and informed decisions across the market. The Global Healthcare markets service presents an analysis of 60 countries with an updated outlook for the pharmaceutical industry. The reports in the service are updated every month and present healthcare expenditure, pharmaceutical sales, pharmaceutical goods trade balance, population forecasts, life expectancy, Consumer Price Inflation, GDP forecast, regulatory analysis, and company profiles. The Pipeline, Epidemiology, and Disease Market Outlook service presents disease pipeline reviews, clinical trial analysis, epidemiology reports, and disease market outlook for over 300 conditions. In addition, Analysis of marketed drugs, upcoming drug candidates, and other information is included in the research solutions. Further, the market size outlook and competitive analysis of medical devices, Healthcare IT, Analytics and Instrumentation, and the Biotechnology industry outlook are analyzed.

Healthcare
Report Name

Wilson's Disease (WD) Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Type (Penicillamine, Trientine, Zinc), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), Countries and Companies Report

Wilson's Disease (WD) Drugs Market is projected to register a 6.6% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00023038  |   No. of Pages: 191

In-vitro Diagnostics Instruments Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Immunochemistry, Clinical Microbiology, Molecular diagnostics, Others), By End-User (Hospitals and diagnostic laboratories, Academic and research institutes, Home care), Countries and Companies Report

In-vitro Diagnostics Instruments Market is projected to register a 5.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022338  |   No. of Pages: 190

Hemostats and Tissue Sealants Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Hemostats, Tissue sealants and adhesives, Fibrin sealants), By End-User (Hospitals, Ambulatory Surgical Centers, Homecare settings, Others), Countries and Companies Report

Hemostats and Tissue Sealants Market is projected to register a 9.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022271  |   No. of Pages: 203

Hemostasis Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Laboratory Analyzers , Point-of-Care Testing Systems), By Test (Activated Partial Thromboplastin Time, D Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, Others), By End-User (Hospitals, Diagnostic Centers, Others), Countries and Companies Report

Hemostasis Diagnostics Market is projected to register a 9.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022270  |   No. of Pages: 198

Gonorrhea Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Gonococcal Infection (Uncomplicated Gonococcal Infection, Gonococcal Arthritis, Gonococcal Meningitis and Endocarditis), By Treatment (Monotherapy, Dual Therapy), By End-User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Countries and Companies Report

Gonorrhea Therapeutics Market is projected to register a 5.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022229  |   No. of Pages: 205

CoQ10 Supplement Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Application (Dietary Supplements, Pharmaceuticals, Cosmetics, Others), Countries and Companies Report

CoQ10 Supplement Market is projected to register a 10.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022004  |   No. of Pages: 193

Clinical Nutrition Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Oral Clinical Nutrition, Parenteral Nutrition, Enteral Feeding Formulas), By Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others), By Sales Channel (Retail Channels, Online Channels, Institutional Sales Channels), Countries and Companies Report

Clinical Nutrition Market is projected to register a 7.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021978  |   No. of Pages: 202

Hyperpigmentation Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Disorder (Albinism, Vitiligo, Melasma, Post-inflammatory Hyperpigmentation (PIH), Others), By Treatment (Topical Treatment, Dermabrasion, Chemical Peels, Laser Treatment, Phototherapy, Others), By End-User (Hospitals, Dermatological clinics, Others), Countries and Companies Report

Hyperpigmentation Treatment Market is projected to register a 8.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00023119  |   No. of Pages: 210

Chronic Disease Management Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Disease (Cardiovascular diseases , Diabetes, Cancer, Asthma, Chronic obstructive pulmonary disorders, Others), By Type (Solutions, Services), By End-User (Healthcare Providers, Healthcare Payers, Others), Countries and Companies Report

Chronic Disease Management Market is projected to register a 14.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021965  |   No. of Pages: 201

Central Nervous System (CNS) Stimulant Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Lisdexamfetamine, Dextroamphetamine, Methylphenidate HCl, Others), By Application (Attention Deficit Hyperactivity Disorder (ADHD), Sleeping Disorder, Others), Countries and Companies Report

Central Nervous System (CNS) Stimulant Drugs Market is projected to register a 6.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021939  |   No. of Pages: 197